128 related articles for article (PubMed ID: 3029619)
1. Specificity of the opioid affinity reagent, DALECK, in a set of isolated tissue assay systems.
Peers E; Shaw JS; Rance MJ; Barnard EA
Neuropeptides; 1986; 8(4):317-25. PubMed ID: 3029619
[TBL] [Abstract][Full Text] [Related]
2. Covalent labeling of opioid receptors with 3H-D-Ala2-Leu5-enkephalin chloromethyl ketone. I. Binding characteristics in rat brain membranes.
Szücs M; Belcheva M; Simon J; Benyhe S; Tóth G; Hepp J; Wollemann M; Medzihradszky K
Life Sci; 1987 Jul; 41(2):177-84. PubMed ID: 3037220
[TBL] [Abstract][Full Text] [Related]
3. Opioid agonist affinity in the guinea-pig ileum and mouse vas deferens.
Porreca F; LoPresti D; Ward SJ
Eur J Pharmacol; 1990 Apr; 179(1-2):129-39. PubMed ID: 2163849
[TBL] [Abstract][Full Text] [Related]
4. Receptors for opioid peptides in the guinea-pig ileum.
Takemori AE; Portoghese PS
J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
[TBL] [Abstract][Full Text] [Related]
5. Covalent labeling of opioid receptors with 3H-D-Ala2-Leu5-enkephalin chloromethyl ketone. II. Binding characteristics in frog brain membranes.
Simon J; Szücs M; Benyhe S; Tóth G; Hepp J; Borsodi A; Wollemann M; Medzihradszky K
Life Sci; 1987 Jul; 41(2):185-92. PubMed ID: 3037221
[TBL] [Abstract][Full Text] [Related]
6. Binding characteristics and analgesic activity of D-ALA2-Leu5-enkephalin chloromethyl ketone.
Szücs M; Benyhe S; Borsodi A; Wollemann M; Jancsó G; Szécsi J; Medzihradszky K
Life Sci; 1983 Jun; 32(24):2777-84. PubMed ID: 6304443
[TBL] [Abstract][Full Text] [Related]
7. Mu-receptor specificity of the opioid peptide irreversible reagent, [3H]DALECK.
Newman EL; Borsodi A; Toth G; Hepp F; Barnard EA
Neuropeptides; 1986; 8(4):305-15. PubMed ID: 3029618
[TBL] [Abstract][Full Text] [Related]
8. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
[TBL] [Abstract][Full Text] [Related]
9. Two new opioid delta-receptor ligands: a highly selective agonist and a potent selective antagonist in in vitro isolated preparations.
Ueki M; Aoki K; Kajiwara M; Shinozaki K; Inoue H; Oka T
Jpn J Pharmacol; 1984 Dec; 36(4):485-9. PubMed ID: 6098760
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profiles of fentanyl analogs at mu, delta and kappa opiate receptors.
Maguire P; Tsai N; Kamal J; Cometta-Morini C; Upton C; Loew G
Eur J Pharmacol; 1992 Mar; 213(2):219-25. PubMed ID: 1355735
[TBL] [Abstract][Full Text] [Related]
11. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
[TBL] [Abstract][Full Text] [Related]
12. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
[TBL] [Abstract][Full Text] [Related]
13. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
Hayes AG; Sheehan MJ; Tyers MB
Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
[TBL] [Abstract][Full Text] [Related]
14. Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: a new highly potent and fully specific agonist for opiate delta-receptors.
Zajac JM; Gacel G; Petit F; Dodey P; Rossignol P; Roques BP
Biochem Biophys Res Commun; 1983 Mar; 111(2):390-7. PubMed ID: 6301470
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive potencies of beta-casomorphin analogs as compared to their affinities towards mu and delta opiate receptor sites in brain and periphery.
Brantl V; Pfeiffer A; Herz A; Henschen A; Lottspeich F
Peptides; 1982; 3(5):793-7. PubMed ID: 6294635
[TBL] [Abstract][Full Text] [Related]
16. CI-977, a novel and selective agonist for the kappa-opioid receptor.
Hunter JC; Leighton GE; Meecham KG; Boyle SJ; Horwell DC; Rees DC; Hughes J
Br J Pharmacol; 1990 Sep; 101(1):183-9. PubMed ID: 2178014
[TBL] [Abstract][Full Text] [Related]
17. Potent morphiceptin analogs: structure activity relationships and morphine-like activities.
Chang KJ; Wei ET; Killian A; Chang JK
J Pharmacol Exp Ther; 1983 Nov; 227(2):403-8. PubMed ID: 6313901
[TBL] [Abstract][Full Text] [Related]
18. Similarity between mu-opioid receptors in mouse vas deferens and guinea-pig ileum.
Goodall J; Hughes IE; Mackay D
Br J Pharmacol; 1985 May; 85(1):277-83. PubMed ID: 2992651
[TBL] [Abstract][Full Text] [Related]
19. Opioid profiles of Cys2-containing enkephalin analogues.
Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
[TBL] [Abstract][Full Text] [Related]
20. Opioid ligand binding sites in the spinal cord of the guinea-pig.
Zarr GD; Werling LL; Brown SR; Cox BM
Neuropharmacology; 1986 May; 25(5):471-80. PubMed ID: 3016586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
